alexa Clinical Nanomedicine|omicsgroup|Journal Of Nanomedicine And Biotherapeutic Discovery|omicsgroup|Journal Of Nanomedicine And Biotherapeutic Discovery

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Nanobiotechnology

Nanobiotechnology is an international peer-reviewed journal that publishes research papers covering all aspects of the emerging and rapidly growing research area at the intersection of nanotechnology, molecular biology and biomedical sciences. Nanobiotechnology serves as an authoritative forum presenting state-of-the-art, multidisciplinary research and technological advances in theory, instrumentation and methods as well as applications in a variety of areas of nanotechnology related to biology and medicine. The convergence of nanotechnology and biomedical sciences opens a wide variety of biological research topics and medical uses at the molecular and cellular level. The long-term goal of Nanobiotechnology is to contribute to the information transfer and to the explosive growth of this important research area. Open Access journals make a quick review of articles and inform the authors within twenty one days of submission with the help of 3000 editorial team and quality review board which is ready to offer useful and informative results. Most of the peer-reviewed open access journals of OMICS Group is indexed in well-known indexing services like PubMed, Scopus, AGORA, ISI, ProQuest, Gale, Chemical Abstracts, and HINARI etc. Articles published in OMICS Group journals are permanently archived in the respective peer reviewed journals thus providing immediate and permanent access to individual papers and application of the scientific information. So, it is providing chance to get attract more number of students towards scientific research.
 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords